TMO vs VRTX
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Vertex Pharmaceuticals Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | VRTX |
|---|---|---|
| Price | $700.22 | $538.60 |
| Market cap | $259.44B | $136.56B |
| P/E ratio | 36.9 | 34.7 |
| ROE | 13.38% | 20.80% |
| Profit margin | 14.94% | 30.70% |
| Revenue growth | 9.10% | 11.80% |
| Dividend yield | 0.27% | 0.00% |
| Beta | 0.84 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs VRTX in plain English
- TMO is the bigger company — about 1.9× the market cap of VRTX.
- VRTX is cheaper on earnings (P/E 34.7 vs 36.9).
- VRTX earns a higher return on equity (21% vs 13%).
- VRTX is growing revenue faster (12% vs 9%).
- TMO pays a dividend (0.27%) while the other effectively doesn't.
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
VRTX return calculator
See what $1,000 in Vertex Pharmaceuticals Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.